Paper423973
Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas.
De Camilli P and 2 others. Nature, 1979. Cited by 269 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas. Papers, record 423973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/423973
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenoma | Major topic |
| Adenylyl Cyclase Inhibitors | Major topic |
| Dopamine | Major topic |
| Pituitary Neoplasms | Major topic |
| Prolactin | Major topic |
| Bromocriptine | |
| Fluphenazine | |
| Humans | |
| Norepinephrine | |
| Receptors, Dopamine |
Source PubMed
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 269 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,348,744 | Neuromodulatory control of energy reserves in dopaminergic neurons. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/41348744 | PubMed |
| 37,047,716 | Unveiling the Differences in Signaling and Regulatory Mechanisms between Dopamine D2 and D3 Receptors and Their Impact on Behavioral Sensitization. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047716 | PubMed |
| 34,385,603 | How changes in dopamine D2 receptor levels alter striatal circuit function and motivation. | Mol Psychiatry | 2022 | https://conductscience.org/library/papers/34385603 | PubMed |
| 33,919,025 | Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson's Disease. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33919025 | PubMed |
| 33,706,940 | Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction. | Adv Pharmacol | 2021 | https://conductscience.org/library/papers/33706940 | PubMed |
| 33,535,394 | Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms. | J Clin Med | 2021 | https://conductscience.org/library/papers/33535394 | PubMed |
| 32,659,920 | Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection. | Biomolecules | 2020 | https://conductscience.org/library/papers/32659920 | PubMed |
| 27,900,635 | Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas. | Pituitary | 2017 | https://conductscience.org/library/papers/27900635 | PubMed |
| 25,254,141 | Pharmacological overview of galactogogues. | Vet Med Int | 2014 | https://conductscience.org/library/papers/25254141 | PubMed |
| 24,957,966 | Light responsive polymer membranes: a review. | Membranes (Basel) | 2012 | https://conductscience.org/library/papers/24957966 | PubMed |
| 23,129,328 | Dopamine receptor signaling and current and future antipsychotic drugs. | Handb Exp Pharmacol | 2012 | https://conductscience.org/library/papers/23129328 | PubMed |
| 23,087,877 | Spontaneous reduction of prolactinoma post cabergoline withdrawal. | Indian J Endocrinol Metab | 2012 | https://conductscience.org/library/papers/23087877 | PubMed |
| 21,653,876 | Estrogen regulation of the dopamine-activated GIRK channel in pituitary lactotrophs: implications for regulation of prolactin release during the estrous cycle. | Am J Physiol Regul Integr Comp Physiol | 2011 | https://conductscience.org/library/papers/21653876 | PubMed |
| 19,909,227 | Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? | Curr Pharm Des | 2010 | https://conductscience.org/library/papers/19909227 | PubMed |
| 17,638,086 | Pituitary development and physiology. | Pituitary | 2007 | https://conductscience.org/library/papers/17638086 | PubMed |
| 17,570,067 | Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline. | Pituitary | 2008 | https://conductscience.org/library/papers/17570067 | PubMed |
| 16,411,068 | Pharmacologic resistance in prolactinoma patients. | Pituitary | 2005 | https://conductscience.org/library/papers/16411068 | PubMed |
| 15,159,529 | Biography of Pietro De Camilli. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15159529 | PubMed |
| 14,674,720 | Dopamine resistance of prolactinomas. | Pituitary | 2003 | https://conductscience.org/library/papers/14674720 | PubMed |
| 11,081,193 | Growth factors in pituitary tumors. | Pituitary | 1999 | https://conductscience.org/library/papers/11081193 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/423973
GET https://conductscience.org/api/papers/v1/423973/cited_by?page=2